Development of a novel clinical staging model for cirrhosis using the Nationwide Inpatient Sample

Journal of Investigative Medicine

Volumn 66, Issue 6, 2018, Pages 992-997

  Haj, Mona ^a   Hart, Mary ^a   Rockey, Don C ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

liver; liver diseases; liver failure

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BLEEDING; CAUSE OF DEATH; CLINICAL ASSESSMENT; CLINICAL OUTCOME; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGUS VARICES; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROGNOSIS; SCORING SYSTEM; ADOLESCENT; COHORT ANALYSIS; MORTALITY; THEORETICAL MODEL; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INPATIENTS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROGNOSIS; UNITED STATES; YOUNG ADULT;

EID: 85047932571     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.1136/jim-2018-000709     Document Type: Article

References (19)

1. Zipprich A, Garcia-Tsao G, Rogowski S, et al. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int 2012;32:1407-14
2. Hoteit MA, Ghazale AH, Bain AJ, et al. Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis. World J Gastroenterol 2008;14:1774-80
3. DAmico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006;44:217-31
4. DAmico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: A 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther 2014;39:1180-93
5. Bosch J, Abraldes JG, Berzigotti A, et al. Portal hypertension and gastrointestinal bleeding. Semin Liver Dis 2008;28:003-25
6. Schmidt ML, Barritt AS, Orman ES, et al. Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology 2015;148:967-77
7. Garcia-Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 2010;51:1445-9
8. DAmico G, Morabito A, DAmico M, et al. Clinical stages of cirrhosis and competing risks. J Hepatol. In Press 2018.
9. Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254-61
10. Mandorfer M, Bota S, Schwabl P, et al. Nonselective blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 2014;146:1680-90
11. Gins P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet 2003;362:1819-27
12. Stepanova M, Mishra A, Venkatesan C, et al. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol 2012;10:1034-41
13. Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol 2016;8:307-21
14. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;40:652-9
15. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007;102:2086-102
16. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: Anything worth doing should be done right. Hepatology 2004;39:280-3
17. Spiegel BM, Esrailian E, Eisen G. The budget impact of endoscopic screening for esophageal varices in cirrhosis. Gastrointest Endosc 2007;66:679-92
18. Spiegel BM, Targownik L, Dulai GS, et al. Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective? Hepatology 2003;37:366-77
19. Singla A, Hart JL, Li Y, et al. Hospitalization for complications of cirrhosis: Does volume matter? J Gastrointest Surg 2011;15:330-5.